| Literature DB >> 31374092 |
Marco Caversaccio1,2, Wilhelm Wimmer1,2, Juan Anso3, Georgios Mantokoudis1, Nicolas Gerber3, Christoph Rathgeb2, Daniel Schneider3, Jan Hermann3, Franca Wagner4, Olivier Scheidegger5, Markus Huth1, Lukas Anschuetz1, Martin Kompis1, Tom Williamson3, Brett Bell3, Kate Gavaghan3, Stefan Weber3.
Abstract
To demonstrate the feasibility of robotic middle ear access in a clinical setting, nine adult patients with severe-to-profound hearing loss indicated for cochlear implantation were included in this clinical trial. A keyhole access tunnel to the tympanic cavity and targeting the round window was planned based on preoperatively acquired computed tomography image data and robotically drilled to the level of the facial recess. Intraoperative imaging was performed to confirm sufficient distance of the drilling trajectory to relevant anatomy. Robotic drilling continued toward the round window. The cochlear access was manually created by the surgeon. Electrode arrays were inserted through the keyhole tunnel under microscopic supervision via a tympanomeatal flap. All patients were successfully implanted with a cochlear implant. In 9 of 9 patients the robotic drilling was planned and performed to the level of the facial recess. In 3 patients, the procedure was reverted to a conventional approach for safety reasons. No change in facial nerve function compared to baseline measurements was observed. Robotic keyhole access for cochlear implantation is feasible. Further improvements to workflow complexity, duration of surgery, and usability including safety assessments are required to enable wider adoption of the procedure.Entities:
Year: 2019 PMID: 31374092 PMCID: PMC6677292 DOI: 10.1371/journal.pone.0220543
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Flowchart for non-randomized trial design.
Study participant details; PTA = pure tone average over 0.5/1/2/4 kHz; CMD = custom made device with shorter electrode lead.
| ID | Age, years | Gender | Side | Unaided PTA, dB HL | Etiology | Hearing loss duration, years | Electrode array |
|---|---|---|---|---|---|---|---|
| 01 | 51 | female | right | 120 | Cogan syndrome | 26 | Flex24 |
| 02 | 49 | male | right | 94 | Menière’s disease | 22 | Flex28 |
| 03 | 39 | female | left | 106 | Progressive hearing loss | 10 | Flex28 |
| 04 | 68 | female | right | 71 | Progressive hearing loss | 12 | Flex28,CMD |
| 05 | 71 | female | right | 88 | Sudden deafness | 5 | Flex28 |
| 06 | 59 | female | left | 89 | Progressive hearing loss | 7 | Flex28,CMD |
| 07 | 60 | male | right | 90 | Progressive hearing loss | 13 | Flex24 |
| 08 | 73 | female | left | 86 | Menière’s disease | 26 | Flex28 |
| 09 | 61 | male | right | 108 | Congenital | 20 | Flex28 |
*existing cochlear implant in contralateral ear.
Fig 2(left) The robotic system with patient. (right) Comparison between conventional and robotic procedure in postoperative computed-tomography slices (subject 06).
Fig 3(left) Patient prepared for intraoperative CBCT imaging. (right) Microscopic inspection of the robotically drilled tunnel (arrow) after reversion to conventional procedure including a mastoidectomy (subject 02).
Summary of results.
IM-dFN is the distance tunnel to facial nerve based on the intraoperative imaging; ACC = effective drilling accuracy at the level of the facial recess; FD-dFN = estimated distance of the drill tunnel to the facial nerve using force-density correlation; DEC = Confirmation for sufficient geometric clearance; Dins = angular insertion depth; SV = scala vestibuli; ST = scala tympani.
| ID | Plan | Robotic drilling phases | Implantation | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| dFN (mm) | i | ii | iii | Scala | Dins (°) | ||||||
| Drill | Geometric safety assessment | Drill | EMG | Drill | |||||||
| IM-dFN (mm) | ACC (mm) | FD-dFN (mm) | DEC | ||||||||
| 01 | 0.73 | ✔ | 0.90 | 0.17 | 1.01 | SV | 360 | ||||
| 02 | 0.63 | DYS | n.a. | 0.12 | Reverted to conventional | ST | 510 | ||||
| 03 | 0.62 | 0.39 | 0.23 | 0.35 | ST | 540 | |||||
| 04 | 0.54 | 0.38 | 0.16 | 0.38 | ST | 525 | |||||
| 05 | 0.72 | 0.67 | 0.05 | 0.78 | ST | 380 | |||||
| 06 | 0.65 | 0.36 | 0.29 | 1.18 | ST | 660 | |||||
| 07 | 0.50 | 0.84 | 0.34 | 0.80 | ST | 440 | |||||
| 08 | 0.51 | 0.22 | 0.29 | 0.16 | Reverted to conventional | ST | 555 | ||||
| 09 | 0.49 | 0.65 | 0.16 | 1.45 | Reverted to conventional | ST | 540 | ||||
| Mean (SD) | 0.60 | 0.55 | 0.21 | 0.69 | 501 | ||||||
1 Scanner dysfunction and subsequent decision to revert due to non-available imaging
2 Decision to revert due to critical distance to facial nerve (value 0.22 mm)
3 Decision to revert due to critical distance to external auditory canal (value 0.19 mm)
Audiological outcomes; PTA = pure tone average over 0.5/1/2/4 kHz.
| Subject | Word recognition (numbers) | Word recognition (monosyllables) | Aided sound field PTA | Active channels | Hearing preservation, % |
|---|---|---|---|---|---|
| 01 | 20/60/60/70 | 0/40/50/60 | 34/26/22/23 | 10 | not assessed |
| 02 | 60/90/90/100 | 30/50/60/60 | 29/29/28/28 | 12 | not assessed |
| 03 | 20/20/40/30 | 0/0/10/50 | 38/39/39/39 | 12 | 61 (partial preservation) |
| 04 | 10/55/60/80 | 20/50/70/60 | 38/34/35/34 | 10 | 21 (minimal preservation) |
| 05 | 80/60/80/80 | 40/10/60/50 | 39/44/40/39 | 9 | not assessed |
| 06 | 100/100/-/- | 30/80/-/- | 38/35/-/- | 12 | 57 (partial preservation) |
| 07 | 100/100/-/- | 60/60/-/- | 34/35/-/- | 11 | 47 (partial preservation) |
| 08 | 60/70/-/- | 20/60/-/- | 35/39/-/- | 12 | not assessed |
| 09 | 40/70/-/- | 10/5/-/- | 44/39/-/- | 12 | 39 (partial preservation) |
†measured 1/3/6/12 months postoperatively;
*partially completed procedure.